Ralph R. Weichselbaum

65.8k total citations · 22 hit papers
707 papers, 48.4k citations indexed

About

Ralph R. Weichselbaum is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Ralph R. Weichselbaum has authored 707 papers receiving a total of 48.4k indexed citations (citations by other indexed papers that have themselves been cited), including 274 papers in Oncology, 244 papers in Molecular Biology and 182 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Ralph R. Weichselbaum's work include Head and Neck Cancer Studies (76 papers), Cancer Immunotherapy and Biomarkers (64 papers) and Advanced Radiotherapy Techniques (60 papers). Ralph R. Weichselbaum is often cited by papers focused on Head and Neck Cancer Studies (76 papers), Cancer Immunotherapy and Biomarkers (64 papers) and Advanced Radiotherapy Techniques (60 papers). Ralph R. Weichselbaum collaborates with scholars based in United States, China and Japan. Ralph R. Weichselbaum's co-authors include Michael A. Beckett, Everett E. Vokes, Yang‐Xin Fu, Donald Küfe, Hua Liang, Wenbin Lin, Byron Burnette, Liufu Deng, Samuel Hellmän and Thomas E. Darga and has published in prestigious journals such as Nature, Science and New England Journal of Medicine.

In The Last Decade

Ralph R. Weichselbaum

695 papers receiving 47.4k citations

Hit Papers

Head and Neck Cancer 1989 2026 2001 2013 1993 2014 2014 2009 1989 500 1000 1.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Head and Neck Cancer
    1993 1.8k citations Ralph R. Weichselbaum et al. profile →
  2. Irradiation and anti–PD-L1 treatment synergistically promote antitumor immunity in mice
    2014 1.6k citations Hua Liang, Byron Burnette et al. profile →
  3. STING-Dependent Cytosolic DNA Sensing Promotes Radiation-Induced Type I Interferon-Dependent Antitumor Immunity in Immunogenic Tumors
    2014 1.5k citations Hua Liang, Byron Burnette et al. profile →
  4. Therapeutic effects of ablative radiation on local tumor require CD8+ T cells: changing strategies for cancer treatment
    2009 1.1k citations Youjin Lee, Sogyong Auh et al. Blood profile →
  5. Accurate Three-Dimensional Registration of CT, PET, and/or MR Images of the Brain
    1989 807 citations Charles A. Pelizzari, Ralph R. Weichselbaum et al. profile →
  6. Radiotherapy and immunotherapy: a beneficial liaison?
    2017 781 citations Ralph R. Weichselbaum, Hua Liang et al. profile →
  7. Anti-tumour immunity controlled through mRNA m6A methylation and YTHDF1 in dendritic cells
    2019 737 citations Xiaona Huang, Ralph R. Weichselbaum et al. profile →
  8. Blockage of the vascular endothelial growth factor stress response increases the antitumor effects of ionizing radiation.
    1999 723 citations Michael A. Beckett, Helena J. Mauceri et al. profile →
  9. The Efficacy of Radiotherapy Relies upon Induction of Type I Interferon–Dependent Innate and Adaptive Immunity
    2011 686 citations Byron Burnette, Hua Liang et al. Cancer Research profile →
  10. Oligometastases revisited
    2011 682 citations Ralph R. Weichselbaum et al. profile →
  11. Core-shell nanoscale coordination polymers combine chemotherapy and photodynamic therapy to potentiate checkpoint blockade cancer immunotherapy
    2016 668 citations Ralph R. Weichselbaum et al. profile →
  12. Nanoscale Metal–Organic Frameworks for Therapeutic, Imaging, and Sensing Applications
    2018 615 citations Ralph R. Weichselbaum et al. profile →
  13. Proteolytic activation of protein kinase C delta by an ICE-like protease in apoptotic cells.
    1995 612 citations Ralph R. Weichselbaum et al. profile →
  14. Low-dose X-ray radiotherapy–radiodynamic therapy via nanoscale metal–organic frameworks enhances checkpoint blockade immunotherapy
    2018 518 citations Charles A. Pelizzari, Yang‐Xin Fu et al. profile →
  15. Chlorin-Based Nanoscale Metal–Organic Framework Systemically Rejects Colorectal Cancers via Synergistic Photodynamic Therapy and Checkpoint Blockade Immunotherapy
    2016 450 citations Ralph R. Weichselbaum et al. profile →
  16. Safety and Clinical Activity of Pembrolizumab and Multisite Stereotactic Body Radiotherapy in Patients With Advanced Solid Tumors
    2018 434 citations Theodore Karrison, Sean P. Pitroda et al. profile →
  17. Photodynamic Therapy Mediated by Nontoxic Core–Shell Nanoparticles Synergizes with Immune Checkpoint Blockade To Elicit Antitumor Immunity and Antimetastatic Effect on Breast Cancer
    2016 411 citations Ralph R. Weichselbaum et al. profile →
  18. Intratumoral accumulation of gut microbiota facilitates CD47-based immunotherapy via STING signaling
    2020 295 citations Ralph R. Weichselbaum, Yang‐Xin Fu et al. profile →
  19. Lactobacillus rhamnosus GG induces cGAS/STING- dependent type I interferon and improves response to immune checkpoint blockade
    2021 220 citations Hua Liang, Ralph R. Weichselbaum et al. profile →
  20. Zinc cyclic di-AMP nanoparticles target and suppress tumours via endothelial STING activation and tumour-associated macrophage reinvigoration
    2022 154 citations Hua Liang, Xiaona Huang et al. profile →
  21. Nanoparticles Synergize Ferroptosis and Cuproptosis to Potentiate Cancer Immunotherapy
    2024 82 citations Ralph R. Weichselbaum et al. profile →
  22. Radiotherapy, immunity, and immune checkpoint inhibitors
    2024 58 citations Sean P. Pitroda, Ralph R. Weichselbaum et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Ralph R. Weichselbaum 18.7k 17.9k 10.6k 9.4k 7.6k 707 48.4k
David L. Rimm 19.9k 1.1× 17.9k 1.0× 7.9k 0.7× 7.0k 0.7× 8.2k 1.1× 547 41.4k
José Baselga 25.8k 1.4× 19.7k 1.1× 14.1k 1.3× 2.6k 0.3× 9.8k 1.3× 484 46.7k
Kevin J. Harrington 13.5k 0.7× 9.2k 0.5× 6.0k 0.6× 5.0k 0.5× 2.6k 0.3× 768 31.6k
Lisa M. Coussens 27.4k 1.5× 23.6k 1.3× 6.3k 0.6× 21.6k 2.3× 12.5k 1.7× 198 61.3k
Elizabeth A. Eisenhauer 15.2k 0.8× 12.0k 0.7× 12.7k 1.2× 3.2k 0.3× 7.3k 1.0× 213 41.9k
Roger Stupp 9.5k 0.5× 15.7k 0.9× 13.9k 1.3× 3.8k 0.4× 10.7k 1.4× 376 49.8k
Razelle Kurzrock 24.9k 1.3× 21.0k 1.2× 12.3k 1.2× 8.2k 0.9× 13.3k 1.8× 1.2k 60.4k
Suzanne L. Topalian 32.6k 1.7× 12.4k 0.7× 7.7k 0.7× 27.0k 2.9× 4.0k 0.5× 215 49.2k
Roy S. Herbst 31.9k 1.7× 17.0k 0.9× 26.5k 2.5× 5.5k 0.6× 9.2k 1.2× 583 50.9k
Carlos Cordon‐Cardo 22.8k 1.2× 41.4k 2.3× 11.0k 1.0× 7.1k 0.8× 12.8k 1.7× 564 68.1k

Countries citing papers authored by Ralph R. Weichselbaum

Since Specialization
Citations

This map shows the geographic impact of Ralph R. Weichselbaum's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ralph R. Weichselbaum with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ralph R. Weichselbaum more than expected).

Fields of papers citing papers by Ralph R. Weichselbaum

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ralph R. Weichselbaum. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ralph R. Weichselbaum. The network helps show where Ralph R. Weichselbaum may publish in the future.

Co-authorship network of co-authors of Ralph R. Weichselbaum

This figure shows the co-authorship network connecting the top 25 collaborators of Ralph R. Weichselbaum. A scholar is included among the top collaborators of Ralph R. Weichselbaum based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ralph R. Weichselbaum. Ralph R. Weichselbaum is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Arina, Ainhoa, Edwin Araúz, Elham Masoumi, et al.. (2025). A universal chimeric antigen receptor (CAR)–fragment antibody binder (FAB) split system for cancer immunotherapy. Science Advances. 11(27). eadv4937–eadv4937.
2.
Voce, David J., Giovanna M. Bernal, Longtao Wu, et al.. (2019). Temozolomide Treatment Induces lncRNA MALAT1 in an NF-κB and p53 Codependent Manner in Glioblastoma. Cancer Research. 79(10). 2536–2548. 78 indexed citations
3.
Pitroda, Sean P., Melinda E. Stack, Lucy Chen, et al.. (2018). JAK2 Inhibitor SAR302503 Abrogates PD-L1 Expression and Targets Therapy-Resistant Non–small Cell Lung Cancers. Molecular Cancer Therapeutics. 17(4). 732–739. 20 indexed citations
4.
Rañoa, Diana Rose E., Ryan C. Widau, Stephen Mallon, et al.. (2018). STING Promotes Homeostasis via Regulation of Cell Proliferation and Chromosomal Stability. Cancer Research. 79(7). 1465–1479. 75 indexed citations
5.
Oshima, Go, Michael J. Bolt, Alexandre Chlenski, et al.. (2018). DNA Methylation Controls Metastasis-Suppressive 14q32-Encoded miRNAs. Cancer Research. 79(3). 650–662. 39 indexed citations
6.
Efimova, Elena V., Edwardine Labay, Helena J. Mauceri, et al.. (2017). HMG-CoA Reductase Inhibition Delays DNA Repair and Promotes Senescence After Tumor Irradiation. Molecular Cancer Therapeutics. 17(2). 407–418. 43 indexed citations
7.
Arina, Ainhoa, et al.. (2017). Transfer of Allogeneic CD4+ T Cells Rescues CD8+ T Cells in Anti-PD-L1–Resistant Tumors Leading to Tumor Eradication. Cancer Immunology Research. 5(2). 127–136. 14 indexed citations
8.
Pitroda, Sean P., Riyue Bao, Jorge Andrade, Ralph R. Weichselbaum, & Philip P. Connell. (2017). Low Recombination Proficiency Score (RPS) Predicts Heightened Sensitivity to DNA-Damaging Chemotherapy in Breast Cancer. Clinical Cancer Research. 23(15). 4493–4500. 13 indexed citations
9.
Mansour, Nassir M., Giovanna M. Bernal, Longtao Wu, et al.. (2015). Decoy Receptor DcR1 Is Induced in a p50/Bcl3–Dependent Manner and Attenuates the Efficacy of Temozolomide. Cancer Research. 75(10). 2039–2048. 15 indexed citations
10.
Efimova, Elena V., Satoe Takahashi, Ding Wu, et al.. (2015). Linking Cancer Metabolism to DNA Repair and Accelerated Senescence. Molecular Cancer Research. 14(2). 173–184. 42 indexed citations
11.
Leisegang, Matthias, Boris Engels, Karin Schreiber, et al.. (2015). Eradication of Large Solid Tumors by Gene Therapy with a T-Cell Receptor Targeting a Single Cancer-Specific Point Mutation. Clinical Cancer Research. 22(11). 2734–2743. 59 indexed citations
12.
Mason, Jennifer M., Hillary L. Logan, Brian Budke, et al.. (2014). The RAD51-Stimulatory Compound RS-1 Can Exploit the RAD51 Overexpression That Exists in Cancer Cells and Tumors. Cancer Research. 74(13). 3546–3555. 41 indexed citations
13.
Elas, Martyna, Eugene D. Barth, Boris Epel, et al.. (2013). EPR Oxygen Images Predict Tumor Control by a 50% Tumor Control Radiation Dose. Cancer Research. 73(17). 5328–5335. 50 indexed citations
14.
Khodarev, Nikolai N., Bernard Roizman, & Ralph R. Weichselbaum. (2012). Molecular Pathways: Interferon/Stat1 Pathway: Role in the Tumor Resistance to Genotoxic Stress and Aggressive Growth. Clinical Cancer Research. 18(11). 3015–3021. 154 indexed citations
15.
Schreiber, Karin, Ainhoa Arina, Boris Engels, et al.. (2012). Spleen Cells from Young but Not Old Immunized Mice Eradicate Large Established Cancers. Clinical Cancer Research. 18(9). 2526–2533. 21 indexed citations
16.
Meng, Yuru, Michael A. Beckett, Hua Liang, et al.. (2010). Blockade of Tumor Necrosis Factor α Signaling in Tumor-Associated Macrophages as a Radiosensitizing Strategy. Cancer Research. 70(4). 1534–1543. 144 indexed citations
17.
Efimova, Elena V., Helena J. Mauceri, Daniel W. Golden, et al.. (2010). Poly(ADP-Ribose) Polymerase Inhibitor Induces Accelerated Senescence in Irradiated Breast Cancer Cells and Tumors. Cancer Research. 70(15). 6277–6282. 98 indexed citations
18.
Lee, Youjin, Sogyong Auh, Yugang Wang, et al.. (2009). Therapeutic effects of ablative radiation on local tumor require CD8+ T cells: changing strategies for cancer treatment. Blood. 114(3). 589–595. 1050 indexed citations breakdown →
19.
Yamini, Bakhtiar, Xiaohong Yu, M. Eileen Dolan, et al.. (2007). Inhibition of Nuclear Factor-κB Activity by Temozolomide Involves O 6-Methylguanine–Induced Inhibition of p65 DNA Binding. Cancer Research. 67(14). 6889–6898. 33 indexed citations
20.
Posner, Mitchell C., James O. Park, Thomas E. Darga, et al.. (2005). Progression of Barrett's Metaplasia to Adenocarcinoma Is Associated with the Suppression of the Transcriptional Programs of Epidermal Differentiation. Cancer Research. 65(8). 3146–3154. 133 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by David L. Rimm Breakdown of academic impact, for papers by José Baselga Breakdown of academic impact, for papers by Kevin J. Harrington Breakdown of academic impact, for papers by Lisa M. Coussens Breakdown of academic impact, for papers by Elizabeth A. Eisenhauer Breakdown of academic impact, for papers by Roger Stupp Breakdown of academic impact, for papers by Razelle Kurzrock Breakdown of academic impact, for papers by Suzanne L. Topalian Breakdown of academic impact, for papers by Roy S. Herbst Breakdown of academic impact, for papers by Carlos Cordon‐Cardo
Rankless by CCL
2026